24/7 Market News Snapshot 24 Jul 2024 – PIERIS PHARMACEUTICALS INC (NASDAQ: PIRS)

Press Release

DENVER, Colo., 24 July, 2024 (247marketnews.com) – (NASDAQ:PIRS) are discussed in this article.
Pieris Pharmaceuticals Inc. (PIRS) has demonstrated impressive market performance today, with shares surging by 111.22% from the opening price of $13.19 to the current trading value of $14.54, accompanied by robust trading volume of 4.6 million shares. This upward momentum suggests heightened investor optimism, possibly in response to recent company developments or industry news. Investors and traders are advised to closely monitor PIRS for potential trading opportunities, given the significant price shift observed during the trading session.

Meanwhile, Halper Sadeh LLC, a prominent investor rights law firm, is initiating an investigation into the fairness of the proposed merger between Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) and Palvella Therapeutics, Inc. focusing on safeguarding the interests of Pieris shareholders. Post-merger, Pieris shareholders are expected to hold an 18% stake in the combined entity.

The investigation scrutinizes whether Pieris and its board adhered to regulatory requirements and fiduciary duties towards shareholders, ensuring they received equitable consideration and adequate information concerning the merger. Shareholders are encouraged to explore their legal rights by contacting Halper Sadeh LLC for potential actions that may enhance shareholder benefits, request further disclosures, or seek redress on behalf of Pieris investors.

Halper Sadeh LLC, known for its global advocacy on behalf of investors impacted by securities fraud, has a proven track record of achieving substantial recoveries and influencing corporate reforms. For detailed information on this investigation and shareholder recourse options, please refer to the original article on BusinessWire.

This release serves as a notification and does not constitute legal advice or a guarantee of future outcomes.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.